From time to time, the Company has entered into sales agreements with agents pursuant to which the Company could issue and sell shares of certain series of its Preferred Stock and class A common stock through ATMs. Pursuant to these agreements, the Company agreed to pay the sales agents commissions for their services in acting as agents with respect to the sale of shares through the at-the-market equity offering programs and also agreed to provide the sales agents with reimbursement for certain incurred expenses and customary indemnification and contribution rights.

As of September 30, 2026, the Company was party to the Omnibus Sales Agreement, pursuant to which the Company may from time to time through the Agents issue and sell shares of STRF Stock, STRC Stock, STRK Stock, STRD Stock, class A common stock and any additional series of preferred stock as may be designated by the Company from time to time in the future.

The following table sets forth total shares sold and net proceeds (net of sales commissions and expenses) received from shares sold under the Company's ATMs for the three and nine months ended September 30, 2026 and 2025.


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Number of shares sold pursuant to at-the-market offerings:
STRF Stock ATMs	—		1,881,542		—		3,448,292
STRC Stock ATMs	—		—		75,307,642		—
STRK Stock ATMs	—		1,404,499		38,796		6,305,866
STRD Stock ATMs	—		557,441		—		557,441
Class A common stock ATMs	50,297,872		5,712,041		108,753,378		32,562,256

Net proceeds received from shares sold pursuant to at-the-market offerings (in thousands):
STRF Stock ATMs	$	—	$	217,434	$	—	$	380,468
STRC Stock ATMs	—		—		7,518,335		—
STRK Stock ATMs	—		152,824		2,968		630,014
STRD Stock ATMs	—		48,462		—		48,462
Class A common stock ATMs	5,406,890		2,199,360		13,642,442		11,847,257
Total	$	5,406,890	$	2,618,080	$	21,163,745	$	12,906,201
Issuance cost adjustments related to STRF, STRK and STRD Stock ATMs (in thousands):	$	—	$	—	$	(45)	$	—

The sales commissions and expenses related to sales of class A common stock described above are considered direct and incremental costs and are charged against “Additional paid-in capital” on the Consolidated Balance Sheet in the period in which the corresponding shares are issued and sold.